Evidence map›Paper›PMID 36397106›Full record

SynthesisMalaria journal2022

HMOX1 STR polymorphism and malaria: an analysis of a large clinical dataset.

Fergus Hamilton, Ruth Mitchell, Aubrey Cunnington, Peter Ghazal, Nicholas J Timpson

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Malaria journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Human genetic variations conferring resistance to malaria.Journal of translational medicine · 2025
    Review
  2. Heme and immunity: The heme oxygenase dichotomy.Journal of inorganic biochemistry · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Fergus HamiltonMRC Integrative Epidemiology Unit, University of Bristol, Oakfield Grove, Bristol, BS8 2BN, UK. Fergus.hamilton@bristol.ac.uk.
Ruth MitchellMRC Integrative Epidemiology Unit, University of Bristol, Oakfield Grove, Bristol, BS8 2BN, UK.
Aubrey CunningtonDepartment of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
Peter GhazalSystem Immunity Research Institute, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
Nicholas J TimpsonMRC Integrative Epidemiology Unit, University of Bristol, Oakfield Grove, Bristol, BS8 2BN, UK.
MRC Epidemiology Unit · GBCardiff University · GBImperial College London · GBNorth Bristol NHS Trust · GB

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC_UU_00011/1Wellcome Trust 202802/Z/16/ZWellcome Trust GW4CAT
6 · The paper itself

Abstract

backgroundInducible expression of heme oxygenase-1 (encoded by the gene HMOX1) may determine protection from heme released during malaria infections. A variable length, short tandem GT(n) repeat (STR) in HMOX1 that may influence gene expression has been associated with outcomes of human malaria in some studies. In this study, an analysis of the association between variation at the STR in HMOX1 on severe malaria and severe malaria subtypes is presented in a large, prospectively collected dataset (MalariaGEN).

methodsThe HMOX1 STR was imputed using a recently developed reference haplotype panel designed for STRs. The STR was classified by total length and split into three alleles based on an observed trimodal distribution of repeat lengths. Logistic regression was used to assess the association between this repeat on cases of severe malaria and severe malaria subtypes (cerebral malaria and severe malarial anaemia). Individual analyses were performed for each MalariaGEN collection site and combined for meta-analysis. One site (Kenya), had detailed clinical metadata, allowing the assessment of the effect of the STR on clinical variables (e.g. parasite count, platelet count) and regression analyses were performed to investigate whether the STR interacted with any clinical variables.

resultsData from 17,960 participants across 11 collection sites were analysed. In logistic regression, there was no strong evidence of association between STR length and severe malaria (Odds Ratio, OR: 0.96, 95% confidence intervals 0.91-1.02 per ten GT(n) repeats), although there did appear to be an association at some sites (e.g., Kenya, OR 0.90, 95% CI 0.82-0.99). There was no evidence of an interaction with any clinical variables.

conclusionsMeta-analysis suggested that increasing HMOX1 STR length is unlikely to be reliably associated with severe malaria. It cannot be ruled out that repeat length may alter risk in specific populations, although whether this is due to chance variation, or true variation due to underlying biology (e.g., gene vs environment interaction) remains unanswered.

Indexed as

Heme Oxygenase-1Malaria, CerebralAllelesGenetic Predisposition to DiseaseHumansPolymorphism, GeneticHeme Oxygenase-1HMOX1 protein, human

Identifiers

PMID36397106
PMCPMC9670449
OpenAlexW4309512517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.